The Handbook of Insurance-Linked Securities

Ed.: Barrieu, Pauline, Albertini, Luca

• Gebundenes Buch

Produktbeschreibung

This book provides a much needed reference for finance practitioners on the rapidly growing Insurance Linked Securities markets. It will provide readers with the state of the art in Insurance-Linked Securitization, introducing the different parties involved in the transactions and their roles, the motivation for the transaction sponsors, the potential inherent pitfalls, the latest developments and transaction structures but also the key challenges faced by the market at each stage. The book will also focus on more general issues faced by the industry, including accounting and tax issues, regulatory issues and solvency capital requirements - all tackled from international perspectives.

The book will be organized into two parts making a distinction between non-life and life securitization in order to accommodate the specificities of each sector. Each chapter covers a specific topic or sector of the market. After a general overview over the ILS market, the Insurance-Linked Securitization process is studied in detail.

Contributions will be from leading practitioners in the field, and will feature case studies and worked examples to illustrate more complicated transactions and techniques.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Wiley Finance Series
• Verlag: Wiley & Sons
• Artikelnr. des Verlages: 14574383000
• 1. Auflage
• Seitenzahl: 400
• Erscheinungstermin: 1. September 2009
• Englisch
• Abmessung: 251mm x 176mm x 30mm
• Gewicht: 834g
• ISBN-13: 9780470743836
• ISBN-10: 0470743832
• Artikelnr.: 26432069

Autorenporträt

About the editors DR PAULINE BARRIEU is a Reader (Associate Professor) at the London School of Economics. She has two PhDs in Mathematics and in Finance. Her research interests are mainly on the study of problems at the interface between finance and insurance, in particular ILS. She also works on quantitative methods for risk measurement and robust decision making, with applications in finance and environmental economics. LUCA ALBERTINI is Chief Executive Officer of Leadenhall Capital Partners, an asset management company dedicated to insurance linked investments strategies. Luca has over 16 year's securitisation experience, having worked at Citibank, GE Capital, Credit Suisse First Boston and at Swiss Re, where he became responsible for the European Insurance Linked Securities team.

Inhaltsangabe

About the Contributors xv
Acknowledgements xxv
1 Introduction 1
Pauline Barrieu and Luca Albertini
Part I Non-life Securitisation 7
2 Non-life Insurance Securitisation: Market Overview, Background and
Evolution 9
Jonathan Spry
2.1 Market overview 9
2.2 Market dynamics 14
2.3 The question of basis risk remains 16
2.4 ILS and the credit crunch 18
3 Cedants' Perspectives on Non-life Securitization 19
3A Insurance-linked securities as part of advanced risk intermediation 21
Insa Adena, Katharina Hartwig and Georg Rindermann
3A.1 Motivation for Allianz to take part in ILS activities 21
3A.2 Objectives of insurance companies 23
3A.3 Case study: Blue Fin Ltd 24
References 28
3B Reinsurance vs Securitisation 29
Guillaume Gorge
3B.1 Keeping risk vs transferring it 29
3B.2 Reinsurance vs securitisation 30
3B.3 Application to main P&C risks 31
3B.4 Case studies: Aura re and Sparc 32
3B.5 Limits and success factors to securitisation 33
References 34
3C Securitisation as a diversification from traditional retrocession 35
Jean-Luc Besson
4 Choice of Triggers 37
Dominik Hagedorn, Christian Heigl, Andreas Müller and Gerold Seidler
4.1 General aspects 37
4.2 Indemnity triggers 38
4.2.1 Scope of coverage 39
4.2.2 Payout timing 39
4.2.3 Loss verification 40
4.2.4 Transparency 40
4.3 Non-indemnity triggers 41
4.3.1 Parametric triggers (pure and index) 41
4.3.2 Industry loss triggers 43
4.3.3 Modelled loss triggers 45
4.4 Choosing the optimal trigger 45
4.4.1 Comparison of trigger types 46
4.4.2 Choice of trigger and alternative solutions 47
5 Basis Risk from the Cedant's Perspective 49
David Ross and Jillian Williams
5.1 Introduction 49
5.2 Investor vs sponsor risk 50
5.3 Trigger types 50
5.4 Catastrophe models 52
5.4.1 Key components of catastrophe models 52
5.4.2 Uncertainty 54
5.5 Sources of basis risk 55
5.5.1 Source 1: Catastrophe model error/shortcomings 55
5.5.2 Source 2: Discrepancy between the modelled index loss and the
modelled company loss 56
5.5.3 Source 3: Dynamic basis risk 56
5.6 Defining basis risk 56
5.7 Quantifying basis risk 58
5.7.1 Measures for pro rata hedges 58
5.7.2 Measures for digital hedges 59
5.7.3 Measuring positive basis risk 59
5.8 Minimising basis risk 60
5.8.1 Over-hedging 60
5.8.2 Choice of index 62
5.8.3 Reset clauses 62
5.8.4 Cat model input 63
5.9 Conclusion 63
Acknowledgements 63
References 64
6 Rating Methodology 65
Cameron Heath
6.1 Standard & Poor's ratings services' rating process 65
6.1.1 Initial interaction 65
6.1.2 Risk analysis 65
6.1.3 Documentation review 67
6.1.4 Transaction closing 67
6.1.5 Surveillance 67
6.2 Risk analysis 68
6.2.1 Trigger options 68
6.2.2 Indemnity vs non-indemnity triggers 68
6.2.3 Risk factors 70
6.2.4 Adjusted probability of default 72
6.2.5 Application of methodology 73
6.2.6 Default table 74
6.2.7 Multi-event criteria 74
6.3 Legal and swap documentation review process 75
6.3.1 Insurance focus points 75
6.3.2 Legal and structural focus points 75
6.4 Impact on sponsor 75
6.4.1 Capital model treatment of ILS 75
6.4.2 Summary of basis risk analysis 76
6.4.3 Sources of basis risk 77
6.4.4 Link to ILS revised probability of attachment 82
References 82
7 Risk Modelling and the Role and Benefits of Cat Indices 83
Ben Brookes
7.1 Components of a cat model 84
7.2 Insurance-linked securities 84
7.2.1 General overview 84
7.2.2 Insurance-linked security triggers 85
7.2.3 Basis risk 90
7.3 Cat indices 93
7.3.1 Property Claims Service (PCS) 93
7.3.2 Re-Ex - NYMEX 93
7.3.3 Insurance Futures Exchange Service (IFEX) 94
7.3.4 Carvill Hurricane Index (CHI) - Chicago Mercantile Exchange (CME) 94
7.3.5 Paradex 95
7.4 Summary 99
8 Legal Issues 101
Malcolm Wattman, Matthew Feig, James Langston, and James Frazier
8.1 The note offering - federal securities law implications 101
8.1.1 The distribution of the notes 101
8.1.2 Application of the anti-fraud provisions of the federal securities
laws 102
8.1.3 Securities offering reform 103
8.1.4 Provision of information 103
8.1.5 The Investment Company Act of 1940 104
8.2 The note offering - the offering circular 104
8.2.1 Important terms 104
8.2.2 ERISA considerations 106
8.2.3 Other considerations regarding the proceeds and payment of interest
109
8.2.4 The risk analysis 110
8.2.5 Opinions 110
8.3 Types of transactions 110
8.3.1 Parametric, index and modeled loss transactions 111
8.3.2 Indemnity transactions 111
8.4 Conclusion 115
9 The Investor Perspective (Non-Life) 117
Luca Albertini
9.1 The creation of a sustainable and liquid market 117
9.1.1 Creation of common terminology 118
9.1.2 Risk analysis 119
9.1.3 Correlation with other investments in the portfolio 119
9.1.4 Relative value 121
9.1.5 Valuation and liquidity 121
9.2 Key transaction features from the investor perspective 122
9.2.1 Assessment of the underlying risks being securitised 122
9.2.2 Risk assessment of the instrument 124
9.2.3 Pricing and risk-return profile 125
9.3 Market evolution: the investor perspective 127
9.3.1 Collateral arrangements 127
9.3.2 Data transparency 128
9.3.3 Exposure monitoring 129
9.3.4 Modelling rigour 129
10 ILS Portfolio Monitoring Systems 131
Tibor Winkler and John Stroughair
10.1 Introduction 131
10.1.1 Completing the circle 131
10.1.2 'Square peg in a round hole?' 132
10.2 Miu - An ILS platform in a convergent space 133
10.2.1 Overview 133
10.2.2 Nuts and bolts - how the platform works 133
10.2.3 Step by step - entering a contract 134
10.2.4 Portfolio analysis 134
10.3 RMS library of cat bond characterisations 137
10.3.1 Motivation and objectives 137
10.3.2 How is it done? A bird's eye view 137
10.3.3 Apples to apples - a leap for the market 138
10.4 Conclusion 138
11 The Evolution and Future of Reinsurance Sidecars 141
Douglas J. Lambert and Kenneth R. Pierce
11.1 A brief history of the brief history of sidecars 142
11.2 Sidecar structures 143
11.2.1 Basic structure 143
11.2.2 Market-facing sidecar 144
11.2.3 Non-market-facing sidecar 145
11.2.4 Capitalising sidecars 146
11.2.5 How sidecars and catastrophe bonds are different 147
11.3 The appeal of sidecars 148
11.3.1 From a cedant/sponsor perspective 148
11.3.2 From an investor perspective 149
11.4 Structuring considerations 149
11.5 The outlook for sidecars 150
11.6 Conclusion 151
12 Case Study: A Cat Bond Transaction by SCOR (Atlas) 153
Emmanuel Durousseau
12.1 Introduction: SCOR's recent history 153
12.2 Atlas III and IV: Background 153
12.3 Atlas: Main characteristics 155
12.4 Basis Risk 158
12.4.1 Reset 158
12.4.2 Gross up 158
12.4.3 Overlap 158
12.4.4 Synthetic covers 159
12.5 Total Return Swap 160
12.6 Conclusion 160
Appendix A 161
A. 1 Definition of events 161
A. 2 Extension events 162
13 Case Study: Swiss Re's New Natural Catastrophe Protection Program (Vega)
163
Jay Green and Jean-Louis Monnier
13.1 A positive evolution of Swiss Re's ILS strategy 163
13.2 Swiss Re accesses multi-event natural catastrophe coverage 164
13.3 The first ILS to use a cash reserve account as credit enhancement 164
13.4 Innovation leads to more efficient protection 165
Part II Life Securitisation 167
14 General Features of Life Insurance-Linked Securitisation 169
Norman Peard
14.1 Life insurer corporate and business structures, risks and products 170
14.1.1 Mutual life offices 170
14.1.2 Proprietary life offices 171
14.1.3 Other forms of life office 173
14.1.4 Principal risks associated with life insurance business 173
14.1.5 Principal product types and associated risks 176
14.2 Actors and their roles 177
14.2.1 Sponsor 177
14.2.2 Investors 179
14.2.3 Regulators 179
14.2.4 External professional advisers 179
14.2.5 Ratings agencies 181
14.2.6 Monoline insurers 181
14.2.7 Liquidity providers 181
14.2.8 Swap providers 182
14.2.9 Others 182
14.3 Process 182
15 Cedants' Perspectives on Life Securitisation 189
15A A cedant's perspective on life securitisation 191
Alison McKie
15A.1 Why securitise? 191
15A.2 Life ILS can be complex 194
15A.3 Outlook for life ILS 198
15B A cedant's perspective on life securitisation 199
Chris Madsen
15B.1 Key considerations 199
15B.2 Examples of securitisation opportunities 202
15B.3 Differences between securitisation and reinsurance 205
16 Rating Methodology 207
Harish Gohil
16.1 Fitch's approach to the rating process 207
16.2 Insurance risk analysis 208
16.2.1 Risk modelling 208
16.2.2 Ratings benchmarks 209
16.2.3 Analysis of sponsor and other counterparties 210
16.2.4 Surveillance 210
16.3 Zest: a VIF case study 211
References 212
17 Life Securitisation: Risk Modelling 213
Steven Schreiber
17.1 Modelling of a catastrophic mortality transaction 213
17.2 Modelling of a VIF transaction 216
18 Life Insurance Securitisation: Legal Issues 219
Jennifer Donohue
18.1 Monetisation of future cash flows 219
18.1.1 Some background on monetisation 219
18.1.2 The market drivers of monetisation 220
18.1.3 Monetisation in the current climate 221
18.1.4 Some transaction structures 221
18.2 Legal aspects of life insurance securitisation - some key features 222
18.2.1 Closed book/open book 222
18.2.2 Unit-linked policies - not 'with profits' policies 222
18.2.3 Risk transfer versus no transfer 222
18.2.4 Warranties 222
18.2.5 Monoline wrap (payment obligation) 223
18.2.6 Recharacterisation risk 223
18.3 Some examples of value-in-force securitisation/monetisation 225
18.3.1 A classical VIF structure: Gracechurch 225
18.3.2 A private but reported transaction: Zest 226
18.4 Outlook 227
19 The Investor Perspective (Life) 229
Luca Albertini
19.1 Life insurance-linked risks and investor appetite 229
19.1.1 The role of the monolines 229
19.1.2 Understanding the risk 230
19.1.3 Correlation with other investments 234
19.1.4 Relative value 236
19.1.5 Valuation and liquidity 237
19.2 Key transaction features from the investor perspective 237
19.2.1 Risk assessment of the instrument 237
19.2.2 Pricing and risk-return profile 240
19.3 Market evolution: the investor perspective 242
20 Longevity Securitisation: Specific Challenges and Transactions 245
Jennifer Donohue, Kirsty Maclean and Norman Peard
20.1 Mortality and longevity risk 245
20.2 A market for longevity risk 246
20.2.1 Potential sources of longevity risk for securitisation 246
20.2.2 Demand for longevity risk 247
20.3 Key structural aspects of longevity risk securitisation 248
20.3.1 Isolating longevity risk 248
20.3.2 Analysis of longevity risks 249
20.3.3 Longevity risk - legal explanation 250
20.3.4 Examples and legal aspects of transaction structures 252
20.4 Some features of longevity risk 255
20.4.1 Model risk 255
20.4.2 Ratings 258
20.4.3 Pricing 258
21 Longevity Risk Transfer: Indices and Capital Market Solutions 261
Guy Coughlan
21.1 The nature of longevity risk 262
21.2 The market for longevity risk transfer 263
21.2.1 Hedgers 263
21.2.2 Investors 265
21.2.3 Intermediaries 265
21.3 Importance of indices, tools and standards 266
21.3.1 Longevity indices 266
21.3.2 Trading and liquidity 268
21.4 Capital market instruments for longevity risk transfer 268
21.4.1 Longevity bond 268
21.4.2 Survivor swap 269
21.4.3 q-forward 269
21.4.4 Survivor forward 271
21.4.5 Instruments and liquidity 272
21.5 Customised vs standardised longevity hedges 273
21.5.1 Customised longevity hedge 273
21.5.2 Standardised index-based longevity hedge 273
21.5.3 Advantages and disadvantages 274
21.6 Case study: customised longevity hedge 274
21.7 Implementing a standardised index-based longevity hedge 275
21.7.1 Liability sensitivity and hedge calibration 276
21.7.2 Hedge effectiveness analysis 278
21.8 Conclusions 280
References 280
22 Case Study: A Cat Mortality Bond by AXA (OSIRIS) 283
Sylvain Coriat
22.1 Catastrophic pandemic risk 283
22.2 Considered risk transfer tools 284
22.3 Detailed structure 285
22.4 Risk analysis 287
22.4.1 Modelling approach 287
22.4.2 Index construction 287
22.5 Investors' reaction 288
22.6 Spread behaviour 288
22.7 Next steps 288
Reference 291
23 Case Study: Some Embedded Value and XXX Securitisations 293
Michael Eakins and Nicola Dondi
23.1 Embedded value securitisation - Avondale S.A. 295
23.2 XXX securitisation 299
Part III Tax and Regulatory Considerations 305
24 The UK Taxation Treatment of Insurance-Linked Securities 307
Adam Blakemore and Oliver Iliffe
24.1 The Directive and the taxation of UK ISPVs 308
24.1.1 The implementation of the Directive in the UK 308
24.1.2 Implementation of the ISPV framework in the UK 308
24.1.3 UK tax treatment of ISPVs 310
24.2 Non-UK insurance special purpose vehicles 315
24.2.1 Tax residence status of the issuer 316
24.2.2 Tax residence status of the issuer's agents 317
24.2.3 Location and management of the issuer's assets 318
24.3 Indirect taxes and withholding of income tax 320
Further reading 321
25 The US Federal Income Taxation Treatment of Insurance-Linked Securities
323
David S. Miller and Shlomo Boehm
25.1 Avoiding US corporate income tax for the issuer 324
25.1.1 Overview 324
25.1.2 Trade or business in the United States 325
25.1.3 Procedures followed by catastrophe bond issuers to avoid substantive
business activities in the United States 326
25.1.4 Section 864(b)(2) safe harbor 328
25.2 Withholding tax and excise tax 328
25.2.1 Overview 328
25.2.2 Descriptions of insurance-linked instruments written on standard
ISDA forms 330
25.2.3 Federal income tax definition of notional principal contracts 331
25.2.4 Put options 334
25.2.5 The Bank of America case (income not clearly described within any
other generally recognised category) 334
25.3 US federal income tax treatment of an investor in a catastrophe bond
issuer: overview 335
25.3.1 US investors 335
25.3.2 Timing and character of income and gain of the issuer with respect
to the permitted investments, the total return swap and the
insurance-linked instrument 338
25.3.3 Foreign investors 339
25.3.4 Notes that are treated as indebtedness for federal income tax
purposes 339
Reference 339
26 Regulatory Issues and Solvency Capital Requirements 341
Mark Nicolaides, Simeon Rudin, Rick Watson and Katharina Hartwig
26.1 Regulatory issues relevant for ILS sponsors 341
26.1.1 Solvency capital 341
26.1.2 Recognition of sponsors' claims against SPV as eligible assets 342
26.2 Solvency I 343
26.2.1 Overview 343
26.2.2 Requirement to maintain a solvency margin 344
26.2.3 Structuring ILS under EU Directives to enhance solvency margins 348
26.3 Solvency II 351
26.3.1 Valuation of assets and liabilities 353
26.3.2 Determination of technical provisions 353
26.3.3 Solvency capital requirement 354
26.3.4 Minimum capital requirement 358
26.3.5 Own funds 359
26.3.6 Investments 360
Appendix A: Standard formula, solvency capital requirement (SCR) 361
A. 1 Calculation of the basic solvency capital requirement 361
A. 2 Calculation of the non-life underwriting risk module 361
A. 3 Calculation of the life underwriting risk module 362
A. 4 Calculation of the market risk module 362
Index 363